Incremental Value of Cystatin C Over Conventional Renal Metrics for Predicting Clinical Response and Outcomes in Cardiac Resynchronization Therapy: The BIOCRT Study

BACKGROUND: Despite the benefit of CRT in select patients with heart failure (HF), there remains significant need for predicting those at risk for adverse outcomes for this effective but costly therapy. CysC, an emerging marker of renal function, is predictive of worsening symptoms and mortality in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cardiol
Main Authors: Chatterjee, Neal A., Singh, Jagmeet P., Szymonifka, Jackie, Deaño, Roderick C., Thai, Wai-ee, Wai, Bryan, Min, James K., Januzzi, James L., Truong, Quynh A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4718799/
https://ncbi.nlm.nih.gov/pubmed/26710332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcard.2015.12.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados